Patients with atrial fibrillation complicated with kidney disease have a high risk of stroke and bleeding, and have some limitations or contraindications to oral anticoagulants. Left atrial appendage closure has been used as an alternative to oral anticoagulation in patients with atrial fibrillation, but its efficacy and safety in patients with atrial fibrillation and chronic kidney disease need to be further confirmed. This paper intends to review the research progress of left atrial appendage occlusion in patients with atrial fibrillation complicated with chronic renal insufficiency.
Citation：
CHEN Min, REN Bangjiaxin, LI Wentao, ZENG Rui. Research progress on left atrial appendage occlusion for the treatment of atrial fibrillation combined with chronic kidney disease. Chinese Journal of Clinical Thoracic and Cardiovascular Surgery, 2024, 31(7): 1066-1070. doi: 10.7507/1007-4848.202302034
Copy
Copyright © the editorial department of Chinese Journal of Clinical Thoracic and Cardiovascular Surgery of West China Medical Publisher. All rights reserved
| 1. |
|
| 2. |
|
| 3. |
|
| 4. |
|
| 5. |
|
| 6. |
|
| 7. |
|
| 8. |
|
| 9. |
|
| 10. |
|
| 11. |
|
| 12. |
|
| 13. |
|
| 14. |
|
| 15. |
|
| 16. |
|
| 17. |
|
| 18. |
|
| 19. |
|
| 20. |
So CY, Cheung GSH, Chan CKY, et al. Effect of chronic kidney disease on left atrial appendage occlusion outcome: A single-centre retrospective analysis. JACC, 2018, 71(11 Supplement): A302.
|
| 21. |
|
| 22. |
Magnocavallo M, Della Rocca D, Van Niekerk C, et al. Peri-procedural complications and long-term outcomes in atrial fibrillation patients stratified for chronic kidney disease severity undergoing leftatrial appendage occlusion: Results from an international, multicenter registry. Euro Heart J, 2022, 24(SUPPL C): C84.
|
| 23. |
|
| 24. |
|
| 25. |
|
| 26. |
Miguel V, Price M, Reddy V, et al. TCT-615: Do patients with CKD benefit from left atrial appendage closure (LAAC) with watchman? JACC, 2016, 68(18 Supplement): B251.
|
| 27. |
|
| 28. |
|
| 29. |
|
| 30. |
|
| 31. |
|
| 32. |
|
| 33. |
|
| 34. |
|
| 35. |
|
| 36. |
|
| 37. |
Manes M, Radin E, Pellù V, et al. Monocentric experience of left atrial appendage occlusion among patients with advanced chronic kidney disease and non-valvular atrial fibrillation. G Ital Nefrol, 2020, 37(1): 2020-vol1.
|
| 38. |
|
- 1.
- 2.
- 3.
- 4.
- 5.
- 6.
- 7.
- 8.
- 9.
- 10.
- 11.
- 12.
- 13.
- 14.
- 15.
- 16.
- 17.
- 18.
- 19.
- 20. So CY, Cheung GSH, Chan CKY, et al. Effect of chronic kidney disease on left atrial appendage occlusion outcome: A single-centre retrospective analysis. JACC, 2018, 71(11 Supplement): A302.
- 21.
- 22. Magnocavallo M, Della Rocca D, Van Niekerk C, et al. Peri-procedural complications and long-term outcomes in atrial fibrillation patients stratified for chronic kidney disease severity undergoing leftatrial appendage occlusion: Results from an international, multicenter registry. Euro Heart J, 2022, 24(SUPPL C): C84.
- 23.
- 24.
- 25.
- 26. Miguel V, Price M, Reddy V, et al. TCT-615: Do patients with CKD benefit from left atrial appendage closure (LAAC) with watchman? JACC, 2016, 68(18 Supplement): B251.
- 27.
- 28.
- 29.
- 30.
- 31.
- 32.
- 33.
- 34.
- 35.
- 36.
- 37. Manes M, Radin E, Pellù V, et al. Monocentric experience of left atrial appendage occlusion among patients with advanced chronic kidney disease and non-valvular atrial fibrillation. G Ital Nefrol, 2020, 37(1): 2020-vol1.
- 38.
